Meet NATIVE.

Humankind Pharma is developing a prefilled syringe to overcome the challenges of multi-dose vials and make insulin accessible in low-resource settings.

As seen on:

We believe that the discovery of insulin belongs to all of humankind, and we are committed to addressing the underserved diabetic worldwide population by increasing global access to insulin.

Humankind Pharma’s mission aligns with the United Nation’s Sustainable Development Goal for Good Health and Wellbeing by 2030.

The Challenge

Insulin is not reliably accessible to half of the diabetics who depend on it. In many parts of the world, the prognosis of diabetes remains unchanged since the discovery of insulin 100 years ago.

The Solution

Humankind Pharma is developing an affordable and stable prefilled insulin syringe to increase global access to insulin injections.